Topics

Bluebird tweaks gene therapy manufacture to clear barrier to launch

06:05 EDT 29 Oct 2019 | BioPharma-Reporter

Bluebird refines gene therapy manufacturing specifications, setting it up to treat first patient with $1.8m beta-thalassemia drug later this year.

Original Article: Bluebird tweaks gene therapy manufacture to clear barrier to launch

NEXT ARTICLE

More From BioPortfolio on "Bluebird tweaks gene therapy manufacture to clear barrier to launch"

Quick Search

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...